These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 31913695)

  • 1. The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment.
    Bikfalvi A; Billottet C
    Am J Physiol Cell Physiol; 2020 Mar; 318(3):C542-C554. PubMed ID: 31913695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR3, a double-edged sword in tumor progression and angiogenesis.
    Billottet C; Quemener C; Bikfalvi A
    Biochim Biophys Acta; 2013 Dec; 1836(2):287-95. PubMed ID: 23994549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
    Reynders N; Abboud D; Baragli A; Noman MZ; Rogister B; Niclou SP; Heveker N; Janji B; Hanson J; Szpakowska M; Chevigné A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31216755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment.
    Neo SY; Lundqvist A
    Adv Exp Med Biol; 2020; 1231():45-51. PubMed ID: 32060845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CXC chemokine ligand 4/CXC chemokine receptor 3-B in breast cancer progression.
    Saahene RO; Wang J; Wang ML; Agbo E; Song H
    Biotech Histochem; 2019 Jan; 94(1):53-59. PubMed ID: 30264586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cytokine Growth Factor Rev; 2011 Feb; 22(1):1-18. PubMed ID: 21111666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CXCL9/10/11-CXCR3 axis: an important component of tumor-promoting and antitumor immunity.
    Pan M; Wei X; Xiang X; Liu Y; Zhou Q; Yang W
    Clin Transl Oncol; 2023 Aug; 25(8):2306-2320. PubMed ID: 37076663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer.
    Quemener C; Baud J; Boyé K; Dubrac A; Billottet C; Soulet F; Darlot F; Dumartin L; Sire M; Grepin R; Daubon T; Rayne F; Wodrich H; Couvelard A; Pineau R; Schilling M; Castronovo V; Sue SC; Clarke K; Lomri A; Khatib AM; Hagedorn M; Prats H; Bikfalvi A
    Cancer Res; 2016 Nov; 76(22):6507-6519. PubMed ID: 27634764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9.
    Ding Q; Xia Y; Ding S; Lu P; Sun L; Liu M
    Oncotarget; 2016 Mar; 7(12):14405-14. PubMed ID: 26883105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
    Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
    J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.
    Struyf S; Salogni L; Burdick MD; Vandercappellen J; Gouwy M; Noppen S; Proost P; Opdenakker G; Parmentier M; Gerard C; Sozzani S; Strieter RM; Van Damme J
    Blood; 2011 Jan; 117(2):480-8. PubMed ID: 20980681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL4 and CXCL4L1 in cancer.
    Ruytinx P; Proost P; Struyf S
    Cytokine; 2018 Sep; 109():65-71. PubMed ID: 29903575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and role of MIG/CXCR3 axis in mantle cell lymphoma.
    Zhu MX; Wan WL; Hong Y; Wang YF; Dong F; Jing HM
    Exp Cell Res; 2020 Dec; 397(2):112365. PubMed ID: 33197439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL9: evidence and contradictions for its role in tumor progression.
    Ding Q; Lu P; Xia Y; Ding S; Fan Y; Li X; Han P; Liu J; Tian D; Liu M
    Cancer Med; 2016 Nov; 5(11):3246-3259. PubMed ID: 27726306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.
    Struyf S; Burdick MD; Peeters E; Van den Broeck K; Dillen C; Proost P; Van Damme J; Strieter RM
    Cancer Res; 2007 Jun; 67(12):5940-8. PubMed ID: 17575164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.
    Furuya M; Suyama T; Usui H; Kasuya Y; Nishiyama M; Tanaka N; Ishiwata I; Nagai Y; Shozu M; Kimura S
    Hum Pathol; 2007 Nov; 38(11):1676-87. PubMed ID: 17707463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase.
    Van Raemdonck K; Gouwy M; Lepers SA; Van Damme J; Struyf S
    Angiogenesis; 2014 Jul; 17(3):631-40. PubMed ID: 24469069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer CXC chemokine networks and tumour angiogenesis.
    Strieter RM; Burdick MD; Mestas J; Gomperts B; Keane MP; Belperio JA
    Eur J Cancer; 2006 Apr; 42(6):768-78. PubMed ID: 16510280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
    Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
    Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors.
    Weng Y; Siciliano SJ; Waldburger KE; Sirotina-Meisher A; Staruch MJ; Daugherty BL; Gould SL; Springer MS; DeMartino JA
    J Biol Chem; 1998 Jul; 273(29):18288-91. PubMed ID: 9660793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.